Clinical Trial

Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy

Name: Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy — clinical trial record (NCT06850454)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated February 27, 2025 (before its estimated January 10, 2026 completion). Its status may not reflect the trial's current state.

Summary

A study comparing efficacy of olanzapine versus placebo to prevent nausea and vomiting from moderate emetic risk chemotherapy

Trial Details

NCT Number	NCT06850454
Lead Sponsor	Mahidol University
Conditions	Chemotherapy Induced Nausea and Vomiting
Enrollment	140 participants
Start Date	2025-01-10
Primary Completion	2026-01-10 (estimated)
Study Completion	2026-01-31 (estimated)
Updated on ClinicalTrials.gov	2025-02-27